News

NB Private Equity Partners Shares Buyback Announcement Details

NB Private Equity Partners Shares Buyback Announcement Details

NB Private Equity Partners Executes Share Buyback

NB Private Equity Partners (“NBPE” or the “Company”) has recently announced a significant financial decision regarding its Class A Shares. This buyback reflects the Company's strategy to enhance shareholder value and optimize its capital structure, following the authority granted by its shareholders.

Details of the Transaction on the London Stock Exchange

This transaction, executed in accordance with a buy-back agreement with Jefferies International Limited, outlines the terms and specifics surrounding the shares repurchased. On June 13, a total of 3,000 Class A Shares were bought back, demonstrating NBPE's commitment to effectively manage and enhance its financial standing.

Transaction Specifics

The purchase details are noteworthy:

  • Date of Purchase: 13 June 2025
  • Shares Purchased: 3,000 Class A Shares
  • Price Range: Highest price paid was £14.10, with the lowest being £14.02.
  • ISIN for Shares: GG00B1ZBD492

All Class A Shares bought back during this transaction will be cancelled, thus decreasing the total outstanding shares to 45,518,711. Following this calculation, the remaining Class A shares held in treasury total 3,150,408. This change is essential for shareholders as the market should focus on the 45,518,711 voting rights when assessing participation in the company.

Impact of the Buyback on Shareholders

The recent buyback initiative is strategic as it is set to impact the overall value and perception of NBPE within the market. The reduction in outstanding shares can lead to an increased value per share, benefitting existing shareholders and drawing in potential investors. This progressive approach showcases the Company’s dedication to maintaining strong performance and maximizing shareholder returns through effective financial management.

Future Outlook

NBPE's investment strategy is centered around direct private equity investments alongside prominent private equity firms globally. The Company operates under NB Alternatives Advisers LLC, with the Investment Manager playing a crucial role in effectively sourcing and managing investments to ensure long-term capital appreciation. By foregoing traditional management fees associated with third-party GPs, NBPE strives to provide a more efficient investment vehicle in the private equity sector.

About NB Private Equity Partners

Founded with the mission of delivering exceptional financial returns, NB Private Equity Partners focuses on strategic investments that promise substantial growth over time. The company not only aims for capital appreciation but also rewards its investors with bi-annual dividends, aligning its interests with those of its shareholders.

Additional Information on Neuberger Berman

Neuberger Berman, the parent company of the Investment Manager, has built a reputation as an employee-owned, independent investment manager. With a history dating back to 1939, Neuberger Berman oversees an extensive portfolio of approximately $515 billion across various asset classes, emphasizing active management and in-depth research. It is recognized as a leading employer in the field, committed to fostering a productive and supportive workplace.

Contact Information

For further engagement and inquiries, please reach out to:

NBPE Investor Relations +44 20 3214 9002
Luke Mason NBPrivateMarketsIR@nb.com

Kaso Legg Communications +44 (0)20 3882 6644

Charles Gorman nbpe@kl-communications.com

Frequently Asked Questions

What is the purpose of the NBPE share buyback?

The share buyback is intended to enhance shareholder value and optimize the company's capital structure.

How many shares were repurchased during this transaction?

A total of 3,000 Class A Shares were repurchased.

What becomes of the shares that are bought back?

All repurchased Class A Shares will be cancelled, reducing the total outstanding shares.

Who manages the investments for NB Private Equity Partners?

The investments are managed by NB Alternatives Advisers LLC, a subsidiary of Neuberger Berman Group LLC.

What is the significance of the ISIN number mentioned?

The ISIN, GG00B1ZBD492, uniquely identifies the Class A Shares for tracking and regulatory purposes.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 234

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
TCL Tablets Arrive on BestBuy.com: What It Means

Updated Category News Views 11

Go Big or Go Home: TCL's Bold Move TCL just dropped a little bombshell that's gonna ripple through the electronics retail market—its tablets and smartphones are now bright and shiny on BestBuy.com. It's like standing at the craps table and before you know it, the stakes have just doubled. Why? Best Buy ain't some hole-in-the-wall spot. It's the premium electronics...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 345

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
Formation Unveils First Solana Tokenized Securities Venue

Updated Category News Views 22

Well, here we go. Formation Securities is setting sail on the high seas of blockchain, aiming to operate a tokenized securities venue (TSV) on Solana. This isn't your garden-variety launch—it's a bold leap into a newer, faster-paced world of trading. Sure, you’ve heard about blockchains before, but this operation marries the traditional rigmarole of the stock market...

Continue Reading
Continuous Insulation Market Grows, Hits $67.74B by 2031

Updated Category News Views 19

Market Trends and Key Drivers Imagine riding a slow but steady bull market in insulation—sounds mundane, but the numbers don't lie. MarketsandMarkets™ had the scoop, predicting the Continuous Insulation Market will balloon from USD 56.98 billion in 2026 to USD 67.74 billion by 2031, putting down roots with a 3.5% CAGR. Now, you and I both know that when real estate...

Continue Reading
Tigo Energy Faces Class Action: Investor Deadline Looms

Updated Category News Views 5

Unpacking Tigo's Rollercoaster: Lawsuit & Market Reaction They sometimes say, "When it rains, it pours." For Tigo Energy, it’s been more a downpour than a drizzle. Here we are, chasing down what's going on with Tigo Energy (NASDAQ:TYGO), fresh off the heels of a class action fuss that's grabbed every investor's attention. If you've got a stake, or even a passing...

Continue Reading
O-I Glass Faces Class Action: Investor Implications

Updated Category News Views 130

O-I Glass in Hot Water Over Misleading Statements I'll tell you, nothing gets my goat quite like uncovering deceptive practices in the corporate world. It seems O-I Glass, Inc. (NYSE: OI), might have played a fast one with its shareholders. The company is staring down the barrel of a class action lawsuit from Schall, Brown & Schwartz LLP, alleging they weren't entirely...

Continue Reading
Photocure Navigates AssureMDx's Medicare Journey

Updated Category News Views 99

Aiming High with AssureMDx Photocure's got this bladder cancer test called AssureMDx that's at the center of its recent moves after acquiring Vesica Health a few months back. This isn't just any test; it's a urine-based, non-invasive way to snag an early look at bladder cancer. With the FDA's Breakthrough Device tag pinned on, they're not just dipping their toes in—this...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 99

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Zabalafin Hydrogel: Promise in Treating Atopic Dermatitis

Updated Category News Views 7

Pioneering a New Path in Dermatology Treatment In the world of dermatology, finding a topical solution that tackles the full spectrum of atopic dermatitis (AD) is as rare as hens' teeth. But here's a twist—in a recent research paper gracing the Journal of Drugs in Dermatology, Alphyn Biologics sheds light on their unique contender, Zabalafin Hydrogel. This ain't your...

Continue Reading

Top 5 Most Recently Viewed Articles

Captain D's Expands Globally with New Franchise Agreement

Updated Category News Views 653

Captain D's Takes a Giant Leap into Global Expansion In a significant move for its global growth strategy, Captain D's, the leading fast-casual seafood restaurant in the nation, has signed a major franchise agreement aimed at establishing its brand in the UK. This new venture marks a noteworthy milestone as the company prepares to serve its renowned seafood offerings to a...

Continue Reading
Understanding Your Rights as an Alto Neuroscience Shareholder

Updated Category News Views 129

Understanding Your Rights as an Alto Neuroscience Shareholder Alto Neuroscience, Inc. (NASDAQ: ANRO) has recently been in the spotlight as shareholder rights issues arise. For those investors who acquired shares, it is important to understand the implications of these developments and the actions that may be available to you. Why Should Shareholders Take Action? As a...

Continue Reading
Taiwan Fund, Inc. Shares Key Stockholder Meeting Outcomes

Updated Category News Views 170

The Taiwan Fund, Inc. Announces Stockholders Meeting Results The Taiwan Fund, Inc. (TWN), a prominent closed-end investment entity, recently revealed the outcomes of its Annual Stockholders Meeting. This important event, focusing on the future direction of the Fund, showcased a solid commitment from investors as they participated in key voting processes. Board of...

Continue Reading
Canadian Solar Inc. Delivers Solid Q2 2025 Financial Results

Updated Category News Views 295

Strong Performance by Canadian Solar Canadian Solar Inc. (NASDAQ: CSIQ) has recently reported its impressive financial results for the second quarter. The highlights include an increase in solar module shipments, reflecting the company's ongoing advancement in the renewable energy sector. Second Quarter Highlights The second quarter showcased a 14% quarter-over-quarter...

Continue Reading
Otto Aviation Partners with Galorath for Enhanced Cost Estimation

Updated Category News Views 219

Otto Aviation Partners with Galorath for Enhanced Estimation In a groundbreaking move, Otto Aviation has made a strategic decision to standardize its operations on Galorath's AI-powered estimation platform. This collaboration is set to significantly enhance Otto's pricing strategies as it ventures into sustainable aerospace projects, aiming to revolutionize the future of...

Continue Reading